期刊文献+

环肽化合物NW-G01的抗癌活性研究 被引量:1

Identification of the anti-tumor activity of cyclic peptide compound NW-G01
原文传递
导出
摘要 目的鉴定环肽化合物NW-G01对肿瘤细胞增殖与凋亡的调控作用。方法利用显微拍照法检测细胞的形态变化,克隆形成实验检测肿瘤细胞的克隆形成能力,MTT实验检测细胞增殖情况,流式细胞术测定细胞凋亡率。结果显微拍照法和MTT实验检测结果表明,NW-G01能抑制多种肿瘤细胞的增殖,其抑制效果具有时间依赖性和浓度依赖性。NW-G01对胃癌细胞SGC-7901的克隆形成能力具有显著抑制作用,并能降低细胞中S期细胞的比例,阻断细胞周期的进程。此外,流式细胞术检测结果表明,NW-G01能剂量依赖性地诱导SGC-7901细胞凋亡。结论环肽化合物NW-G01能抑制肿瘤细胞增殖,并诱导肿瘤细胞凋亡,在细胞水平具有显著的抗癌活性。 Objective To identify the effect of cyclic peptide compound NW-G01 on tumor cell proliferation and apoptosis. Methods Microphotography was used to detect cell morphological changes. MTT method was used to determine tumor cell proliferation,and the clonogenic survival assay was used to measure the effect of NW-G01 on tumor cell colony formation. Cell cycle was determined by measuring the percentage of Ed U positive cells and apoptosis was analyzed by flow cytometry. Results NW-G01 inhibited proliferation of various tumor cell lines in a dose-and time-dependent manner,and the IC50 ranged from 9 to 30 μmol/L after 72 h treatment. Moreover,NW-G01 significantly suppressed the colony formation of SGC-7901 cells and decreased the percentage of S phase cells. In addition,NW-G01 dose-dependently induced apoptosis of SGC-7901 cells. Conclusion NW-G01 significantly induces cell proliferation inhibition and apoptosis in tumor cells,indicating that NW-G01 is a promising compound for tumor treatment.
作者 王丽丽 谢秀祯 陈国柱 WANG Li-li;XIE Xiu-zhen;CHEN Guo-zhu(College of Life Science,Hainan Normal University,Haikou 571158,China;Institute of Military Cognition and Brain Sciences,Academy of Military Medical Sciences,Academy of Military Sciences,Beijing 100850,China)
出处 《军事医学》 CAS CSCD 北大核心 2018年第9期701-705,714,共6页 Military Medical Sciences
基金 国家自然科学基金资助项目(31201041) 国家重大科技专项重大新药创制资助项目(2014ZX09304313-003)
关键词 环肽化合物 NW-G01 细胞增殖 细胞凋亡 抗肿瘤药 cyclic peptide compound NW-G01 cell proliferation apoptosis antineoplastic agents
  • 相关文献

参考文献7

二级参考文献69

  • 1钟灼,张思群,肖桂元,罗蔚桓,全佩城,冯愉态.微量肝素治疗播散性血管内凝血的临床研究[J].临床血液学杂志,1994,7(3):106-110. 被引量:9
  • 2甄永苏,薛玉川,邵荣光.烯二炔类新抗生素C1027的抗肿瘤作用研究[J].中国抗生素杂志,1994,19(2):164-168. 被引量:31
  • 3郭长升,唐家宏,宋宗昌,朱璐.VAD方案联合全反式维甲酸治疗难治性多发性骨髓瘤12例[J].第三军医大学学报,2006,28(24). 被引量:3
  • 4争光霉素协作组.平阳霉素治疗恶性肿瘤的临床疗效评价[J].中华肿瘤杂志,1979,1:172-174.
  • 5邓春晓,梁桂珍,邓才英.单纯亚砷酸联合维甲酸治疗急性早幼粒细胞白血病不良反应6年观察及对策[J].齐齐哈尔医学院学报,2007,28(12):1411-1412. 被引量:7
  • 6McGahon A,Bissonnette R,Schmitt M,et al. BCR/ABL maintains resistance of chronic myelogenous leukemia cells to apoptotic cell death[J]. Blood, 1994, 83:1179.
  • 7Jaroslaw Dziegielewski,Terry A B. Cellular responses to the DNA strand-scission enediyne C-1027 can be independent of ATM, ATR, and DNA-PK kinases[J]. J Biol Chem, 2002, 277(23):20549.
  • 8Hashiguchi N, Kubota T, Koh J, et al. TZT-1027, elucidates antitumors activity through direct cytotoxicity and selective blockade of blood supply [ J ]. Anticancer Res,2004, 24(4):2201-2208.
  • 9Schoffski P, Thate B, Beutel G, et al. Phase I and pharmacokinetic study of TZT-1027, a novel synthetic dolastatin 10 derivative, administered as a 1-hour intravenous infusion every 3 weeks in patients with advanced refractory cancer[ J].Ann Oncol, 2004, 15(4) :671-679.
  • 10Brandon E F, Sparidans R W, Meijerman I, et al. In vitro characterization of the biotransformation of thiocoraline, a novel marine anti-cancer drug[J]. Invest New Drugs, 2004,22(3): 241-251.

共引文献28

同被引文献8

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部